Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients

Richard P. Wenzel, A Marciniak, C C Kibbler et al.|Journal of Antimicrobial Chemotherapy|2005

Cited by 66